Specialty Diagnostix Scandinavia ApS: Financial statements 2025
CVR: 45427536
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Specialty Diagnostix Scandinavia ApS (CVR 45427536) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,628,798 and a net result of DKK 700,284. Equity in the 2025 report amounted to DKK 4,768,208. The solvency ratio was 91.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,628,798
- Profit/Loss
- DKK 700,284
- Equity
- DKK 4,768,208
- Total Assets
- DKK 5,211,266
- Employees
- 1
Official annual report
How creditworthy is Specialty Diagnostix Scandinavia ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of February 18, 2025, Leif Brix Gottschalk is registered as director of Specialty Diagnostix Scandinavia ApS.
As of February 18, 2025, Leif Brix Gottschalk is registered as an owner of Specialty Diagnostix Scandinavia ApS with an ownership share of 100%.
Specialty Diagnostix Scandinavia ApS was founded on February 18, 2025.
About Specialty Diagnostix Scandinavia ApS
Specialty Diagnostix Scandinavia ApS is a Danish company of the type Anpartsselskab based in Humlebæk, founded in 2025. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Leif Brix Gottschalk. The company is owned by Leif Brix Gottschalk. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,628,798 and a net result of DKK 700,284. Equity in the 2025 report amounted to DKK 4,768,208.
